VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 588 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2015. The put-call ratio across all filers is 2.30 and the average weighting 1.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $29,002,000 | +48.8% | 1,246,774 | +1.8% | 0.03% | +45.5% |
Q1 2018 | $19,490,000 | -23.5% | 1,224,242 | -0.2% | 0.02% | -18.5% |
Q4 2017 | $25,482,000 | +76.8% | 1,226,232 | +21.9% | 0.03% | +58.8% |
Q3 2017 | $14,415,000 | -21.6% | 1,005,933 | -5.0% | 0.02% | -22.7% |
Q2 2017 | $18,376,000 | +65.2% | 1,059,100 | +5.0% | 0.02% | +57.1% |
Q1 2017 | $11,124,000 | +3.3% | 1,008,571 | +35.9% | 0.01% | -6.7% |
Q4 2016 | $10,773,000 | -41.3% | 741,896 | -0.7% | 0.02% | -44.4% |
Q3 2016 | $18,342,000 | +18.0% | 747,110 | -3.2% | 0.03% | +12.5% |
Q2 2016 | $15,546,000 | -33.0% | 771,878 | -10.0% | 0.02% | +20.0% |
Q1 2016 | $23,213,000 | -87.3% | 857,497 | -52.5% | 0.02% | -88.5% |
Q4 2015 | $183,452,000 | -45.6% | 1,804,747 | -4.5% | 0.17% | -51.1% |
Q3 2015 | $337,055,000 | +57.0% | 1,889,536 | +95.5% | 0.36% | +39.1% |
Q2 2015 | $214,725,000 | +12.7% | 966,577 | +0.8% | 0.26% | +5.8% |
Q1 2015 | $190,463,000 | +258.4% | 958,932 | +158.2% | 0.24% | +214.3% |
Q4 2014 | $53,148,000 | -56.4% | 371,379 | -57.3% | 0.08% | -57.2% |
Q3 2014 | $121,959,000 | +24.6% | 870,076 | +12.1% | 0.18% | +21.6% |
Q2 2014 | $97,912,000 | -46.9% | 776,338 | -40.1% | 0.15% | -49.5% |
Q1 2014 | $184,238,000 | +97.8% | 1,295,711 | +69.7% | 0.29% | +102.1% |
Q4 2013 | $93,128,000 | +17.7% | 763,435 | +2.6% | 0.14% | +9.8% |
Q3 2013 | $79,128,000 | +39.8% | 744,302 | +17.2% | 0.13% | +23.4% |
Q2 2013 | $56,613,000 | – | 635,034 | – | 0.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Chou Associates Management | 1,648,992 | $38,323,000 | 14.52% |
Paulson & Co. | 20,839,035 | $484,299,000 | 9.89% |
MILLER VALUE PARTNERS, LLC | 4,999,064 | $116,178,000 | 4.34% |
GoldenTree Asset Management | 1,140,205 | $26,498,000 | 4.21% |
Pomelo Capital LLC | 1,760,000 | $40,902,000 | 4.00% |
Bruce & Co., Inc. | 860,000 | $19,986,000 | 3.98% |
ValueAct Holdings | 18,033,149 | $419,090,000 | 3.79% |
Stanley Capital Management, LLC | 318,400 | $7,400,000 | 3.25% |
Kazazian Asset Management, LLC | 134,784 | $3,132,000 | 2.87% |
Phoenix Investment Adviser LLC | 58,400 | $1,357,000 | 2.48% |